NCT07724691 Spinal Mobilization With Arm Movement and Kaltenborn Mobilization in Adhesive Capsulitis
| NCT ID | NCT07724691 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-07-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-07-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compare the effects of spinal mobilization with arm movement and Kaltenborn Mobilization on pain, range of motion, functional reaching, and disability in patients with Adhesive Capsulitis.
Eligibility Criteria
Inclusion Criteria: * Age 35-50 years * Both male and female genders * Pain rating 3 to 7 on NPRS for at least 3 months * Idiopathic frozen shoulder * Stage II and III frozen shoulder * Positive Apley's Scratch test * Unilateral frozen shoulder * Frozen shoulder with at least 25% restricted ROM * Presence of global restriction in passive range of motion (PROM) in a capsular pattern (ER \> ABD \> IR) Exclusion Criteria: * Arthritic shoulder * Rotator cuff disease * Post-traumatic stiff shoulder * Post-CABG shoulder-hand syndrome * Post-stroke frozen shoulder * Bilateral frozen shoulder * Complex Regional Pain Syndrome * Any fracture or other injury * Any systemic illness * Any inflammatory disease (Rheumatoid arthritis, gout) * Any neurological disease * Frozen Shoulder secondary to Brachial Plexus Injury, Parkinsonism, Ankylosis, Infection, or Arthroplasty * Tendon calcification
Contact & Investigator
Annum Manzoor, MS OMPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07724691 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 50 Years, studying Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07724691 currently recruiting?
Yes, NCT07724691 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07724691 trial being conducted?
This trial is being conducted at Lahore, Pakistan, Lahore, Pakistan.
Who is sponsoring the NCT07724691 clinical trial?
NCT07724691 is sponsored by Riphah International University. The principal investigator is Annum Manzoor, MS OMPT at Riphah International University. The trial plans to enroll 50 participants.